Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

New application of supporting and brain-promoting medicinal composition to treatment of elevated serum lipid

A technology of composition and medicine, which is applied in the field of new pharmaceutical application of Peiyuan Tongnao pharmaceutical composition, and can solve the problems such as hyperlipidemia of Peiyuan Tongnao preparation that has not been disclosed

Inactive Publication Date: 2012-07-04
HENAN LINGRUI PHARMA
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there is no report on whether the Peiyuan Tongnao preparation can treat hyperlipidemia in the prior art literature
There is also no report on the use of compound preparations with the same three or more ingredients as Peiyuan Tongnao Formula, including capsules, tablets, or granules, for regulating blood lipids

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • New application of supporting and brain-promoting medicinal composition to treatment of elevated serum lipid

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0020] 1. Materials and methods

[0021] 1.1 General Information

[0022] A total of 164 patients with hyperlipidemia were observed from August 2008 to March 2010, including 84 cases in the treatment group: 55 males and 29 females, with an average age of (66.15±6.43) years; 80 cases in the control group: 49 males Cases, 31 females, mean age (67.06±5.52) years old. There was no significant difference in gender and age classification between the two groups (P>0.05). The average course of disease in the treatment group was (50.49±29.34) days, and the average course of disease in the observation group was (52.09±30.92) days, and there was no significant difference between the two groups.

[0023] 1.2 Case selection

[0024] The diagnosis of hyperlipidemia is based on the standards proposed in my country's 1997 "Proposals for the Prevention and Treatment of Dyslipidemia": ① hypercholesterolemia is defined as simple total cholesterol (TC) ≥ 5.72mmol / L; ② hypertriglyceridemia is d...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of a supporting and brain-promoting medicinal composition to the preparation of medicaments for treating elevated serum lipid. Compared with a control group, the invention has the advantage that supporting and brain-promoting capsules for oral administration can regulate serum lipid.

Description

technical field [0001] The invention relates to a new pharmaceutical application of a Chinese patent medicine, in particular to a new pharmaceutical application of a Peiyuan Tongnao medicinal composition. Background technique [0002] Hyperlipidemia is a common clinical disease, and its incidence rate increases significantly with age. Hyperlipidemia plays an important role in the pathogenesis of arteriosclerosis, coronary heart disease, and obesity, and has aroused widespread concern. In China, the prevention and treatment of cardiovascular and cerebrovascular diseases has been included in public health, and treated equally with the prevention and treatment of infectious diseases. Under normal circumstances, most of the blood lipids can seep into the arterial wall from the arterial intima, and then be discharged by the lymphatic vessels of the arterial adventitia, so they will not be deposited on the arterial wall. However, under the influence of long-term high-sugar and hi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/8965A61P3/06A61K35/32A61K35/56A61K35/62A61K35/64A61K35/586A61K35/646
Inventor 熊维政张军兵程建军肖冬华李志红武惠斌卢玉斌姜家书
Owner HENAN LINGRUI PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products